Pyrimethamine HCL Micronised

Whatsapp Order

Pyrimethamine HCL Micronised is a finely ground form of pyrimethamine hydrochloride, an antimalarial and antiparasitic drug. The micronised form enhances bioavailability by improving dissolution rate and absorption. It acts by inhibiting dihydrofolate reductase, interfering with folic acid metabolism in protozoa and some bacteria, thus effectively treating malaria and toxoplasmosis. This pharmaceutical-grade compound is used primarily in combination therapies for parasitic infections.

Description

Primary Uses

Pharmaceutical Industry
Used as an active pharmaceutical ingredient (API) in antimalarial medications, often combined with sulfadoxine (e.g., Fansidar) for treating Plasmodium falciparum malaria.

Employed in the treatment of toxoplasmosis, especially in immunocompromised patients.

Utilized in combination therapy for other parasitic infections sensitive to folate pathway inhibition.

Secondary Uses

Veterinary Medicine
Used in veterinary antiparasitic formulations for protozoal infections in animals.

Research & Development
Utilized in pharmaceutical research for new antimalarial drug development and formulation studies.

Used as a reference standard in analytical and pharmacokinetic studies.

PRODUCT KEY FEATURES

 

Basic Identification Attributes
Chemical Name (IUPAC): 5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine hydrochloride

Common/Trade Name: Pyrimethamine HCL Micronised

CAS Number: 145-62-8

HS Code: 2933.99.90

Synonyms: Daraprim (brand name), Pyrimethamine hydrochloride

Physical & Chemical Properties
Physical State: Fine white to off-white powder

Solubility: Slightly soluble in water; soluble in dilute acids

Particle Size: Micronised for enhanced dissolution

Molecular Weight: 248.7 g/mol (free base), hydrochloride salt varies slightly

Odor & Color: Odorless; white powder

 

Safety & Hazard Attributes
GHS Classification: Harmful if swallowed; may cause skin and eye irritation

Toxicity: Moderate toxicity; handle with care to avoid exposure

Exposure Limits: Follow pharmaceutical safety guidelines

Storage & Handling Attributes
Storage Conditions: Store in a tightly closed container in a cool, dry, and well-ventilated area protected from light

Container Type: Sealed plastic or glass containers, foil-lined bags

Shelf Life: Typically 2–3 years if stored properly

Handling Precautions: Use gloves, mask, and eye protection; avoid dust inhalation

 

Regulatory & Compliance Attributes
Complies with USP/NF monograph for pyrimethamine hydrochloride

Manufactured under GMP conditions for pharmaceutical use

 

Environmental & Health Impact
Biodegradability: Not readily biodegradable

Ecotoxicity: Toxic to aquatic organisms at high concentrations

Bioaccumulation: Not significant

SAFETY HANDLING PRECAUTIONS

PPE Required: Gloves, dust mask, goggles recommended

Handling Guidelines: Use in well-ventilated areas; avoid skin and eye contact

Storage Measures: Keep containers tightly closed and stored in a dry, cool environment away from light

 

First Aid Measures
Inhalation: Move to fresh air; seek medical attention if symptoms develop

Skin Contact: Wash with soap and water; seek medical advice if irritation persists

Eye Contact: Rinse with plenty of water for 15 minutes; seek medical attention if irritation continues

Ingestion: Do not induce vomiting; seek immediate medical attention

 

Firefighting Measures
Fire Hazards: Not highly flammable but may decompose on heating releasing toxic fumes

Extinguishing Media: Use water spray, foam, dry chemical, or COâ‚‚

Special Precautions: Wear protective clothing and self-contained breathing apparatus

Hazardous Combustion Products: Carbon oxides, nitrogen oxides, hydrogen chloride